We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

116 hedge funds and large institutions have $143M invested in VanEck Biotech ETF in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 34 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

68.34% more ownership

Funds ownership: 33.48% → 101.82% (+68%)

3% more funds holding

Funds holding: 113 → 116 (+3)

6% less capital invested

Capital invested by funds: $151M → $143M (-$8.64M)

32% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 34

Holders
116
Holders Change
+3
Holders Change %
+2.65%
% of All Funds
1.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
23
Reduced
34
Closed
7
Calls
$960K
Puts
–
Net Calls
+$960K
Net Calls Change
+$960K

Top Buyers

Rank Fund Capital Flow
1
GA
GFS Advisors
Texas
+$289M
2
Wells Fargo
Wells Fargo
California
+$9.85M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.74M
4
ACA
Atlas Capital Advisors
Wyoming
+$932K
5
Jones Financial Companies
Jones Financial Companies
Missouri
+$434K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$10.9M
2
VWM
Valley Wealth Managers
New Jersey
-$3.21M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$3.14M
4
CIG
Consolidated Investment Group
Colorado
-$2.21M
5
Jane Street
Jane Street
New York
-$1.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMT
101
Founders Capital Management (Texas)
Texas
$16.8K – – –
WT
102
Whittier Trust
California
$16.8K – – –
FP
103
Financial Perspectives
Minnesota
$14.8K – – –
HWM
104
HighMark Wealth Management
Minnesota
$13.5K – – –
National Bank of Canada
105
National Bank of Canada
Quebec, Canada
$12.6K – – –
WIM
106
Westside Investment Management
California
$11K – – –
NA
107
NewEdge Advisors
Louisiana
$6.45K – – –
GA
108
GFS Advisors
Texas
$6K +$289M +1,768,590 New
CPA
109
Cardiff Park Advisors
California
$5.89K – – –
AIP
110
Ameritas Investment Partners
Nebraska
$5.05K – – –
PP
111
Pacifica Partners
Canada
$4.18K – – –
Qube Research & Technologies (QRT)
112
Qube Research & Technologies (QRT)
United Kingdom
$4.04K – – –
VAG
113
VisionPoint Advisory Group
Texas
$2.02K – – –
VanEck Associates
114
VanEck Associates
New York
$2K -$1.15K -7 -33%
IAIM
115
International Assets Investment Management
Florida
$1.88K +$1.8K +11 New
BHWM
116
Beaird Harris Wealth Management
Texas
$1.18K – – –
VWM
117
Valley Wealth Managers
New Jersey
– -$3.21M -19,308 Closed
QPBE
118
Quintet Private Bank (Europe)
Luxembourg
– -$662K -3,452 Closed
HWM
119
Howard Wealth Management
Connecticut
– -$203K -1,218 Closed
PA
120
Parallel Advisors
California
– -$69.9K -420 Closed
FDCDDQ
121
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$49.9K -300 Closed
TC
122
Truvestments Capital
Florida
– -$41.6K -250 Closed
First Manhattan
123
First Manhattan
New York
– -$24.9K -150 Closed
1 2 3 4
5

BBH Hedge Fund Activity: Q2 2024 in Review

116 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2024, worth a combined $143M — down 5.7% from $151M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BBH positions and 7 closed out — a net gain of 5 holders — while 23 added to existing stakes and 34 trimmed.

The largest buyer was GFS Advisors, opening a new position worth an estimated $289M. The largest seller was JP Morgan Chase, cutting an estimated $10.9M.

  • 116 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2024, up from 113 in Q1 2024.
  • Funds reported $143M of VanEck Biotech ETF stock for Q2 2024, down 5.7% quarter-over-quarter.
  • 12 funds opened new VanEck Biotech ETF positions in Q2 2024 and 7 closed out, a net change of +5 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2024 was GFS Advisors, an estimated $289M added.
  • The largest VanEck Biotech ETF seller in Q2 2024 was JP Morgan Chase, an estimated $10.9M sold.

Based on aggregated 13F filings for Q2 2024.